← Back to Search

Carbon Fiber Custom Dynamic Orthosis for Acute Lymphoblastic Leukemia (CDOKNEEpilot Trial)

N/A
Waitlist Available
Led By Jason M Wilken
Research Sponsored by University of Iowa
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights

CDOKNEEpilot Trial Summary

This trial will test the effect of two types of shoe inserts, medial and lateral wedges, on people with knee osteoarthritis. The study will compare how well the inserts work to relieve pain and improve function, compared to no insert at all.

Eligible Conditions
  • Acute Lymphoblastic Leukemia
  • Healthy Subjects

CDOKNEEpilot Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Four Square Step Test (4SST)
Knee Range of Motion
Modified Socket Comfort Score (Comfort)
+3 more
Secondary outcome measures
Ankle Range of Motion
Peak Ankle Moment
Peak Ankle Power
+1 more
Other outcome measures
Center of Pressure Velocity Magnitude
Center of Pressure Velocity Timing
Semi-Structured Interview

CDOKNEEpilot Trial Design

6Treatment groups
Experimental Treatment
Group I: Arm 6Experimental Treatment2 Interventions
Testing Order: NoCDO, Lateral, CDO, Medial
Group II: Arm 5Experimental Treatment2 Interventions
Testing Order: NoCDO, Lateral, Medial, CDO
Group III: Arm 4Experimental Treatment2 Interventions
Testing Order: NoCDO, Medial, Lateral, CDO
Group IV: Arm 3Experimental Treatment2 Interventions
Testing Order: NoCDO, Medial, CDO, Lateral
Group V: Arm 2Experimental Treatment2 Interventions
Testing Order: NoCDO, CDO, Medial, Lateral
Group VI: Arm 1Experimental Treatment2 Interventions
Testing Order: NoCDO, CDO, Lateral, Medial
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Carbon Fiber Custom Dynamic Orthosis
2022
N/A
~20
Medial or Lateral Wedge
2022
N/A
~20

Find a Location

Who is running the clinical trial?

University of IowaLead Sponsor
446 Previous Clinical Trials
879,482 Total Patients Enrolled
Jason M WilkenPrincipal InvestigatorUniversity of Iowa

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

For whom is this experiment best suited?

"To be considered for inclusion in this trial, applicants must have reached the age of majority and their age should fall between 18 to 45 years. This medical study will accept a maximum of 20 participants."

Answered by AI

How many participants have been enrolled in this research endeavor?

"Affirmative. According to clinicaltrials.gov, the search for suitable candidates is ongoing as of June 20th 2022. This research project, which was first launched on May 9th 2022, requires a total of twenty participants from one site alone."

Answered by AI

Does this investigation accept participants who have not yet reached retirement age?

"According to the eligibility requirements, participants must be of legal age and no older than 45 years old."

Answered by AI

Are there any slots available for volunteers in this clinical research?

"In accordance with clinicaltrials.gov, this experimental trial is currently seeking participants after first being posted on May 9th 2022 and lastly edited on June 20th 2022."

Answered by AI

What are the primary objectives of this medical experiment?

"This medical trial aims to measure the Peak Ankle Moment over a set baseline. Secondary objectives include assessing Timing of peak center of pressure velocity (percent stance) during gait., Ankle range of motion (degrees) while walking, and calculating Peak ankle power (W/kg)."

Answered by AI
~7 spots leftby Apr 2025